| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.4 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |